Canada markets closed

Protagenic Therapeutics, Inc. (PTIX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.3850-0.0650 (-4.48%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
1,478
3,320
1,589
1,137
699.797
Selling General and Administrative
2,285
1,207
1,969
3,004
1,852
Total Operating Expenses
3,763
4,527
3,558
4,140
2,552
Operating Income or Loss
-3,763
-4,527
-3,558
-4,140
-2,552
Interest Expense
164.819
107.682
137.456
496.912
246.178
Total Other Income/Expenses Net
-42.472
-630.317
-46.051
81.184
248.552
Income Before Tax
-3,845
-5,000
-3,556
-4,523
-2,549
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-3,845
-5,000
-3,556
-4,523
-2,549
Net Income
-3,845
-5,000
-3,556
-4,523
-2,549
Net Income available to common shareholders
-3,845
-5,000
-3,556
-4,523
-2,549
Basic EPS
-0.91
-1.15
-0.82
-1.24
-1.00
Diluted EPS
-0.91
-1.15
-0.82
-1.24
-1.00
Basic Average Shares
4,326
4,345
4,318
3,685
2,585
Diluted Average Shares
4,326
4,345
4,318
3,685
2,585